Table 1 Demographic and clinical characteristics of the two groups
From: Braden scale for assessing pneumonia after acute ischaemic stroke
Items | No pneumonia (n = 357) | Pneumonia (n = 57) | P value |
|---|---|---|---|
Age/year | 71.0 ± 8.9 | 74.7 ± 7.5 | 0.001 |
Male (case, %) | 225 (63.0) | 39 (68.4) | 0.462 |
Smoking status (case, %) | 140 (39.2) | 28 (49.1) | 0.191 |
Drinking status (case, %) | 147 (27.4) | 22 (38.6) | 0.773 |
Hypertension (case, %) | 195 (54.6) | 34 (59.6) | 0.642 |
Hyperlipidemia (case, %) | 101 (28.3) | 12 (21.1) | 0.336 |
Diabetes (case, %) | 96 (26.9) | 18 (31.6) | 0.523 |
Stroke/TIA (case, %) | 36 (10.1) | 5 (8.8) | 1.000 |
COPD (case, %) | 6 (1.7) | 4 (7.0) | 0.036 |
Dysphagia (case, %) | 54 (15.1) | 18 (31.6) | 0.004 |
Admission GCS score | 14.0 ± 2.2 | 10.9 ± 4.3 | 0.000 |
Fasting blood glucose (mmol/L) | 5.9 ± 1.6 | 5.8 ± 0.76 | 0.255 |
Glycosylated hemoglobin (%) | 5.8 ± 0.7 | 5.8 ± 0.7 | 0.822 |
Serum creatinine (umol/L) | 80.4 ± 20.6 | 82.0 ± 25.1 | 0.595 |
Systolic blood pressure (mmHg) | 145.5 ± 17.7 | 143.1 ± 17.4 | 0.342 |
Diastolic blood pressure (mmHg) | 87.3 ± 10.9 | 89.4 ± 10.0 | 0.189 |
Total cholesterol (mmol/L) | 5.0 ± 1.2 | 5.2 ± 1.6 | 0.329 |
Triglyceride (mmol/L) | 1.5 ± 0.8 | 1.4 ± 0.5 | 0.594 |
Low density lipoprotein cholesterol (mmol/L) | 3.1 ± 0.8 | 3.1 ± 0.8 | 0.955 |
High density lipoprotein cholesterol (mmol/L) | 1.2 ± 0.5 | 1.2 ± 0.4 | 0.571 |
Stroke classification | |||
Large atherosclerotic stroke(case, %) | 140 (39.2) | 26 (45.6) | 0.384 |
Arteriolar occlusive stroke(case, %) | 90 (25.2) | 19 (33.3) | 0.199 |
Cardiogenic cerebral embolism(case, %) | 49 (13.7) | 3 (5.3) | 0.085 |
Other stroke with definite etiology(case, %) | 34 (10.0) | 3 (5.3) | 0.452 |
Stroke of unknown etiology(case, %) | 44 (12.3) | 6 (10.5) | 0.829 |
Admission NIHSS score | 9.2 ± 3.6 | 13.6 ± 5.0 | 0.000 |
Braden scale at 24 h | 19.6 ± 2.3 | 15.3 ± 2.5 | 0.000 |